2026 midyear eye care conference review: Key clinical takeaways
Optometry's meetings thus far reveal a field in motion: earlier glaucoma intervention, an expanding dry eye pipeline, breakthrough myopia data, and sharper contact lens and retinal evaluation.
The first half of 2026 brought a packed slate of optometric meetings, each spotlighting where the field is heading next. Glaucoma care saw renewed momentum behind earlier intervention and collaborative models, while dry eye discussions pointed to a fast-expanding therapeutic pipeline. Myopia control research delivered some of the year's most striking data, and sessions on contact lenses and retinal disease underscored how much patient evaluation continues to evolve. Below is a chronological recap of key sessions from EnVision Summit, SECO, Vision Expo, ARVO, and AOA's Optometry's Meeting.
